2024
Impact of Financial Costs on Patients' Fertility Preservation Decisions: An Examination of Qualitative Data from Female Young Adults with Cancer and Oncology Providers
Dorfman C, Stalls J, Shelby R, Arthur S, Acharya K, Davidson B, Corbett C, Greenup R. Impact of Financial Costs on Patients' Fertility Preservation Decisions: An Examination of Qualitative Data from Female Young Adults with Cancer and Oncology Providers. Journal Of Adolescent And Young Adult Oncology 2024, 13: 502-513. PMID: 38294823, DOI: 10.1089/jayao.2023.0108.Peer-Reviewed Original ResearchFertility preservation decisionsFertility preservationImpact of financial costsFemale young adultsYoung adultsFamily building goalsHistory of cancerPreservation decisionsInsurance coverageOncology providersProviders expressed concernsCancer patientsComprehensive cancer centerReproductive ageCancer CenterNational Cancer Institute-designated comprehensive cancer centerCancer Institute-designated comprehensive cancer centerReproductive specialistsPatientsBuilding goalsCancer
2023
Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans
Leraas H, Beckhorn C, Washabaugh C, Thamby J, Greenup R, Haines K, Allen L, Tracy E. Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans. Journal Of Pediatric Surgery 2023, 59: 129-133. PMID: 37858391, DOI: 10.1016/j.jpedsurg.2023.09.022.Peer-Reviewed Original ResearchConceptsComprehensive Cancer Control ProgramPediatric cancer careCancer careChildhood cancerEarly detectionPediatric cancer survivorshipComprehensive cancer control plansDistrict of ColumbiaCancer control programsCancer control plansAdult cancer riskU.S. territoriesTreatment disparitiesPediatric oncologyRisk factorsCancer preventionLevel IVCancer survivorshipCancer riskPediatric cancerChildhood exposureCancerCancer treatmentCareTribal organizationsSurgery in the Setting of Metastatic Breast Cancer
Plichta J, Taskindoust M, Greenup R. Surgery in the Setting of Metastatic Breast Cancer. Current Breast Cancer Reports 2023, 15: 37-47. DOI: 10.1007/s12609-023-00476-4.Peer-Reviewed Original ResearchMetastatic breast cancerSurvival benefitBreast cancerSurgical resectionPrimary tumorSelect patient groupsPotential survival benefitPrimary breast tumorsLocoregional treatmentMetastatic diseaseMost patientsPatient groupProspective studyRetrospective studySelect subgroupClinical scenariosBreast tumorsResectionTumorsCancerLimited benefitSurgeryPatientsMixed resultsDisease
2022
Genetic testing in privately insured women with surgically treated breast cancer
Dinan M, Pitafi S, Greenup R, Long J, Gross C. Genetic testing in privately insured women with surgically treated breast cancer. Breast Cancer Research And Treatment 2022, 198: 177-181. PMID: 36542252, DOI: 10.1007/s10549-022-06829-4.Peer-Reviewed Original ResearchConceptsBreast cancerGenetic testingRoutine breast cancer careBRCA1/BRCA2 genetic testingHormone receptor statusBreast cancer careInvasive breast cancerBRCA2 genetic testingReceptor statusWomen 50Cancer careAge 45Family historyOlder womenInsurer databaseYoung womenCancerWomenCoverage policiesUnclear implicationsPatientsSurgeryPurposeRatesYearsPrevalenceModifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment
Fayanju O, Oyekunle T, Thomas S, Ingraham K, Fish L, Greenup R, Oeffinger K, Zafar S, Hyslop T, Hwang E, Patierno S, Barrett N. Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment. The American Journal Of Surgery 2022, 225: 617-629. PMID: 36411107, PMCID: PMC10085670, DOI: 10.1016/j.amjsurg.2022.10.059.Peer-Reviewed Original ResearchConceptsColorectal cancer screeningModifiable factorsCancer screeningGuideline-concordant screeningPatient-reported factorsHealthy dietary habitsHealth assessmentCommunity-based sampleColorectal screeningColorectal cancerDietary habitsDisease preventionMedical careBehavioral interventionsLess breastBreastLifestyle choicesCentral North CarolinaProstateCancerScreeningCommunity eventsGreater knowledgeFactorsNegative attitudes
2021
ASO Visual Abstract: Contralateral Axillary Nodal Metastases—Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?
Nash A, Thomas S, Plichta J, Fayanju O, Hwang E, Greenup R, Rosenberger L. ASO Visual Abstract: Contralateral Axillary Nodal Metastases—Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer? Annals Of Surgical Oncology 2021, 28: 608-609. DOI: 10.1245/s10434-021-10605-x.Peer-Reviewed Original Research
2016
A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer
Whitley M, Cardona D, Lazarides A, Spasojevic I, Ferrer J, Cahill J, Lee C, Snuderl M, Blazer D, Hwang E, Greenup R, Mosca P, Mito J, Cuneo K, Larrier N, O'Reilly E, Riedel R, Eward W, Strasfeld D, Fukumura D, Jain R, Lee W, Griffith L, Bawendi M, Kirsch D, Brigman B. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Science Translational Medicine 2016, 8: 320ra4. PMID: 26738797, PMCID: PMC4794335, DOI: 10.1126/scitranslmed.aad0293.Peer-Reviewed Original ResearchConceptsSoft tissue sarcomasLocal recurrenceTumor bedClinical trialsIntravenous injectionPhase 1 clinical trialHuman phase 1 clinical trialCo-clinical studiesMicroscopic residual cancerPositive surgical marginsFuture clinical trialsCo-clinical trialsRates of reexcisionAdjuvant therapyResidual cancerSurgical marginsTreatment failureTissue sarcomasBreast cancerCommon causeIntraoperative detectionMouse modelPharmacokinetic profileSolid tumorsCancer
2014
Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer
Greenup R, Peppercorn J, Worni M, Hwang E. Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2014, 21: 1512-1514. PMID: 24577813, DOI: 10.1245/s10434-014-3605-x.Peer-Reviewed Original Research